Akt/cAMP-Responsive Element Binding Protein/Cyclin D1 Network: A Novel Target for Prostate Cancer Inhibition in Transgenic Adenocarcinoma of Mouse Prostate Model Mediated by Nexrutine, a <i>Phellodendron Amurense</i> Bark Extract
Addanki P. Kumar(The University of Texas at San Antonio Health Science Center), Rita Ghosh(The University of Texas Health Science Center at San Antonio)
Cited by 95
Related Papers
Inhibition of PI3K/AKT/mTOR axis disrupts oxidative stress-mediated survival of melanoma cells
|Oncotarget|2015|102
SETD6 regulates NF-κB signaling in urothelial cell survival: Implications for bladder cancer
|Oncotarget|2017|36
Crosstalk between RON and androgen receptor signaling in the development of castration resistant prostate cancer
|Oncotarget|2016|18
SIRT1 inhibition‐induced senescence as a strategy to prevent prostate cancer progression
|Molecular Carcinogenesis|2022|11